Experiments with chlorpromazine, an inhibitor of peroxisomal carnitine octanoyltransferase, have led to the proposal that peroxisomal 0-oxidation which was depressed by the phenothiazine in isolated hepatocytes (1) was dependent on carnitine (2). On the other hand, the inhibition of both cytochrome c oxidase and chlorpromazine palmitoyltransferase activities (2) were proposed as the cause of the reduced ketone body formation from long-
chain fatty acids (1) in isolated hepatocytes incubated in the presence of chlorpromazine at concentrations between 0.4 to 1.0 mM.
In several circumstances, in vivo inhibition of mitochondrial fatty acid oxidation in rodents is associated with peroxisomal proliferation. The latter phenomenon mainly consists of an increased peroxisomal population and enhanced capacity of the peroxisomal P-oxidation. One example is treatment of rodents with 2-oxiran carboxylic acid derivatives such as POCA which are well-known inhibitors of hepatic carnitine palmitoyltransferase type I and which produce a peroxisomal proliferation in liver (3). Another example is given by treatment of mice with valproic acid (4, 5) .
Chlorpromazine, unlike 2-oxiran carboxylates, has been reported to produce lipid accumulation but no induction of peroxisomal proliferation in rodent livers (6) . This discrepancy between the in vztro property of chlorpromazine to inhibit mitochondrial fatty acid oxidation and the failure of the drug to increase, in vivo, the peroxisomal population and 0-oxidation capacity is only apparent. Indeed, we demonstrate that a diet containing 0.5% (w/w) chlorpromazine causes peroxisomal proliferation in liver and heart. On the other hand, we report that the diet containing only 0.1% (w/w) chlorpromazine is unable to induce peroxisomal proliferation and we cannot conclude that this drug concentration inhibits mitochondrial fatty acid oxidation in vivo. In the treated animals, impairment of peroxisomal fatty acid oxidation could occur as attested by a lipid deposition in liver cells mimicking the storage of very long-chain fatty acids in tissues from patients with peroxisomal disorders and by the accumulation of the very long-chain substrates in plasma. The effects of the administration to mice of the chlorpromazinecontaining diets are compared with those of a 0.1 % (w/w) POCA and high fat [20% oleate-(w/w)] diets.
MATERIALS AND METHODS
Adult male NMRI mice, weighing at least 28 g, were used. Control mice were fed on a standard animal food. Treated animals were fed on a diet obtained by mixing the powdered animal food with either 0.1 % clofibric acid, 0.1 % POCA, 20% oleate, and 0.1 or 0.5% chlorpromazine.
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analyse distinct cells, taken from ribbons separated by a t least 20 calculate the volume fraction o r m e m b r a n e area. For the recordk m . T h e magnification was determined with a grating replica (E. ing a n d processing of morphometrical data, a n Apple I1 plus F. Fullam Inc., Schenectady, NY). A multipurpose test grid (Apple Computer, Inc. Cupertino, CA) was used. similar to that described by Weibel et al. (16) was used to
Very long-chain fatty acids were measured i n plasma, each Fig. 2 . Effects of various treatments of mice on the activity and sedimentability of heart peroxisomal enzymes. A, untreated mice; B, C, and D, mice receiving 4 days of the 0.1 % POCA, 20% oleate, and 0.5% chlorpromazine-containing diets, respectively. The supernatant (SN) and pellet (P) fractions were obtained after high spced centrifugation (3,000,000 X g min) of the postnuclear supernatants (6,000 X g min) from, in each condition, six pooled myocardia. The values reported in histograms are the means calculated from results of three separate experiments. The enzyme activities are expressed as nmol ( m u ) or pmol (U) of substrate consumed or product formed per min per ml of fraction. Each (SN or P) fraction corresponds to 200 mg of myocardium/ml. PPO, peroxisomal palmitoyl-CoA oxidase (Hz02 production); PLO, peroxisomal lauroyl-CoA oxidase (Hz02 production); CILO, cyanide-insensitive lauroyl-CoA oxidation (NADH production). effect on liver peroxisomal b-oxidation, catalase, or carnitine acyltransferase activities (Table 1) . Prolonged treatment with 0.1% chlorpromazine (1 month) did not further modify these enzyme activities (not shown). By contrast, in livers from animals given the 0.1 % clofibrate or 0.1 % POCA-containing diet for 1 wk, an enhanced capacity of peroxisomal @-oxidation as well as increased carnitine acyltransferase activities were measured (Table I). The administration of 0.1 % chlorpromazine-containing diet failed to increase the activity of the peroxisomal 8-oxidation in heart (not shown).
Administrution to Mice oj'u 0.5% Chlorpromuzine-C'ontuining
Dict. The higher dose of chlorpromazine was effective after 4 days in producing increased liver peroxisomal @-oxidizing capacity and proliferation of hepatic peroxisomes (see below). The effects of this treatment on liver enzymology were less pronounced than those obtained under 0.1 % POCA treatment and of the same magnitude as those found after a high fat diet ( Table  2 ). The hepatic enzymes were affected differently by the treatments and, in livers from the 0.5% chlorpromazine-treated mice, the activities of palmitoyl-CoA oxidase, lauroyl-CoA oxidase, and cyanide-insensitive lauroyl-CoA oxidation were increased 5-fold; those of carnitine acyltransferases were approximately 2- fold highcr-. while catalasc. glycolate osidase. uratc oxidasc. and butyryl-('oA dchydr-ogcnasc activiticr as well as niitochorldrial palniitoylc:u-nitinc oxidation were nol-ma1 or decreased ( l.ablc 2). l lcart pcroxisomal indi~ction was rninimal in mice receiving I'OC'A :rnd optimal in the :tnirnal giver1 0.5% chlorprom:~/inc 01-high lilt dicts. Riochcmical changes charactcri/ing the pesoxisoma1 proliferation in the heart wcrc the enhancement ofcarnitinc octanoyltransScrasc (not shown). c:rtal;~sc and ~,crosisornal $-oxitfizing activities, and a higher propor-tion of these :~ctivitics linked to sctlimcntablcs par-ticlcs (1-ig. 7) .
,4~lo~)/rologic~rr/ .\/liclic~\ '1-he pcroxisornal population was studied by light and electron microscopy in liver and he:^^? fsom 0. I % I'O('A-, 20% oleate-. 0.1 and 0.5% clilorproni:l/ine-trc:1tc~i rnicc and cornpal-cd with controls. Iluring the adrninistratiori of' the 0. I ' %, cI1lo1-proriia/inc-corit~~iriirig dict, an abnormal occurrcncc of lipid dl-oplets was observed in livcr cytosol but no signilicant change waj induced at the Icvcl of'pcro\isornal pol,-~llation in livcr anti heart. I,ipid I)ro/)lc~/.\ In hcpatoc) tcs fiorn anirnals rccci\.ing the 0.5% clilor-proma~inc-co1it:1i1ii11g dict. the number of lipid droplets was increaseti I-clati~c to the control liver cclls \vliilc a pcculias aspect of the smooth cndoplasmic ~rcticuluni was noticed. l ' h e accumulation ol' lipid droplcts ~~1 s also obscl-vcd in liepatoc!tes from 0.1 %I IJ0('A-and 20'1; olcatc-tr-catcd mice. ?'he characteristics of this :ibnorrnal a c c u r~i~~l a t i o n of lipid drol,lcts arc gi\cn in 'l'ablc 3. ('onvcr-sclq t o l i~c r . n o abnormal accumulation of lipid droplets was seen in cardiac cells from trcatcd :lnimals.
I'c~ro.\~.sotrrol I'ro/i/i~rci/iotr. l'crosisomcs were incrcascd in siye and number in hcpatocytej from trcatcd animals (-I'ablc 3). 'l'hc increase of tlic pcroxisomal volume frl~ction was maximal aficrl'O('A. fiy contrajt \.zit11 per-oxisomcj. little or n o change in the mitochondrial population could be recorded. I'hc ratio bctuccn the pcroxisomal and the mitochondrial volume fractions here equal to 0.07. 0.7 1. 0. 13. anti 0. I6 in liver-5 fiom thc coritr-01. the 0. l %, I'OC'A-, 709,'' olcatc-, and 0.5% chlorprorna~inc-t1~c:~tcc1 animals, rcspccti\cly. I'hc ratio between the perosisornal and the mitochondri:iI crivclopc sur-fi~ccs also was incrcascd after treatment ('l'ablc 3). I-igul-c 3 illustr~ltcs thc pcroxisoni;~l proliftration in livcr-I'rorn mice given the 0.5% chlorpr-orna~inc trcatnicnt.
In myocar.dial cclls, incrcascd numbers of microbodies were obscr-vcd 4 days aficr-the onset of' the treatments of mice with the 0. I I'O('A-. 10% olcatc-. and 0.5%) chlorproma/~nc-containing dicts (I.'ig. 4) . Plic pcroxisornal nature of these cellular structures was strong11 suppor-tcd by thcir cytoclicmical reaction ti)r catalasc. Maximal pel-oxisornc proliferation in heart cclls was obtained aficr administration ol'olcatc and chlol-proma~inc while POC'A treatment was less clticicnt (1-ig. 5 ) .
I,r~t~c~llrir ,Clt.~rc~/iirc,\. 'Plic 0. 1 and 0.5% chlorl,roma/~ne tscatmcnts rcsultcd in tlic ahnormal occurrence of'lanicllar stl-ucttlres in the livcr c).tosol (1:ig. 6). 'l'hc latter material was more kcqucntly sccri i r i thc anim:~ls rccci\.irig the lower dose of chlorpr-omazinc. it is similar to that ohscrvcd in cytosol or in lgsosomcs fi-om livcr or other tissues of patients suflkr-ing koni pcroxisomal deficiency syndromes (1-ig. 0) and is classically believed to rcpresent very long-chain fit11 acid deposition (18) (19) (20) (21) (22) . In the 0. 1 % chlorproma/inc-tr-c:~tccf animals. the deficient oxidation of' \.el-> long-chain fatty acitis was conlirmcd by thcir :lccurnulation in plasma; the (',(,/( ' . ratio [I-atio bctwccn cerotic and bchcnic (('?,) acids] was incrcascci 3-to 3-li)ld (23) .
('lrr~rr,yo.\ itrcllic~c~rl iii li,'c,r. f'croxisornal proliferation in li\.erfroni rodents in a var-icty of' conditions has been documented cxtensivcly (12. 24) . In most cases it consists of'thc enhanccmcnt of both pcroxisornal jj-oxidi~ing activities and pcroxisoniul volume fractions. In addition to the ~)croxisomal changes. incr-cased ability of mitochondria to o x i d i~c fhtty acids also has been reported (25) (26) (27) . Ilicts containing 0. I?;, PPOCA. 20'id olcate. anti most probablg 0.5"; chlor~)rorna/~nc Icad to tlie inliihit~on or chronic o\crlontiing of mitocliond~-ial i:~tt! acid ox~dation. 111-duction of pero\isonial prolif2ration is a i.omrnori clial-actcristic, of'thcse animal models.
In the animals r e c c i \~i n~ a 0. I ''c clilor-~~rorna1iri~-co1~t:1i1iiri~ dict. no peroxisomal prolifcratiori occt~rs. 111 this cxsc. the pel--osisomal htt! acid oxidation is imp:~ir-cd i t ) 1 .ir.o as attcstcii I ) ! the deficient o\idation of \.ti-> long-chain ti~tt! acicls. I .amcllar. structures that are 5irnilar to the inclusions in tlie c.cr-c~I>roliepa-torenal s!.ndromc (Zcll\vcgcr disease) and inli~ntilc liclkum discase livers and in adrenolcuhod!~tr-o~>li! brain arc ohser-\cd in licpatocgtes fi-on1 0.5"; chlorproma/inc-t~.catcti animals and compared xith lamclla~-\ t r~r c t~~~-c s in a patient nit11 ticlicicnt ac) I-CoA osidase. 'Tlicsc structtlrcs arc helie\ cti to hc clic.it~.d I>\-the \\ell-known storage 01' \.el-\ long-cli:~in li~tt! acidr in thcsc diseascs (IS. 28). Phc shoi-tcning of \el-! long-chain \~~t x t r -:~t~r has been demonstrated to bc catalg/ctl 17) the pcro\isomcs (79. 31). Multilamcllar struct~ircs also h a \ c been dcscr~hcti in Ihrosornes from tissues csposcd to cationic anipliipl~ili~ ill'~igr tli:~t inliihit I!sosornnl phosl~liolipid dcgr-:~dation (37-i-1). In our c\-per-iments. tlic incl-case of \.cr> long-cli:~in li~tt! acids in pl:~sma supports the idea that lamellar strt~ctt~rcs rcl)r-c'scrll ICI-! lorig- chain fatty acid deposition consecutive to the inhibition (in vivo) of peroxisomal fatty acid oxidation. Both mechanisms (deficient phospholipid degradation and peroxisomal fatty acid oxidation) may operate simultaneously in the genesis of the lamellar structures in chlorpromazine-treated mouse livers.
The mouse liver carnitine acyltransferases are inhibited by chlorpromazine and are not inactivated by the phenothiazine. Indeed, the activity of these enzymes measured on liver homogenates are normal and increased in mice given the 0.1 and 0.5% chlorpromazine-containing diets, respectively.
Peroxisomal proliferation also takes place in the myocardium. Both biochemical and cytochemical aspects of heart peroxisomal induction have been studied in previous works. In rodents, peroxisomal 0-oxidation activity has been measured in the heart (35, 36) as well as its enhancement when partially hydrogenated fish oil or soybean oil are included in the diet (37) . The morphological description of heart peroxisomes in rodents, but also in primates, has been given previously (38) . Fahimi et al. (39) have demonstrated that ethanol in the diet was efficient enough in rats to increase myocardial catalase activity and the number of heart DAB-reactive organelles. The increase of heart peroxisomes has also been described in mice given phytol (15) . With the present work, we demonstrate the parallelism that exists between the number of DAB-positive organelles and the activity and sedimentability of catalase and peroxisomal 8-oxidation. As was suggested for liver, the propensity of the treatments to induce peroxisomal proliferation in the heart might be correlated to their ability to depress mitochondrial fatty acid oxidation in this tissue.
